EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study

Hao Wang, Mengze Gan iD, Bihao Wu, Rui Zeng, Zhen Wang, Jun Xu, Jia Li, Yandi Zhang, Jinge Cao, Li Chen, Dongsheng Di, Siyuan Peng und 23 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28380 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Hao Wang und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health and Department of Epidemiology and Biostatistics, Ministry of Education and State Key Laboratory …. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children are the high‐risk group for COVID‐19, and in need of vaccination. However, humoral and cellular immune responses of COVID‐19 vaccine remain unclear in vaccinated children. To establish the rational immunization strategy of inactivated COVID‐19 vaccine for children, the immunogenicity of either one dose or two doses of the vaccine in children was evaluated. A prospective cohort study of 322 children receiving inactivated COVID‐19 vaccine was established in China. The baseline was conducted after 28 days of the first dose, and the follow‐up was conducted after 28 days of the second dose. The median titers of receptor binding domain (RBD)‐IgG, and neutralizing antibody (NAb) against prototype strain and Omicron variant after the second dose increased significantly compared to those after the first dose (first dose: 70.0, [interquartile range, 30.0–151.0] vs. second dose: 1261.0 [636.0–2060.0] for RBD‐IgG; 2.5 [2.5–18.6] vs. 252.0 [138.6–462.1] for NAb against prototype strain; 2.5 [2.5–2.5] vs. 15.0 [7.8–26.5] for NAb against Omicron variant, all p < 0.05). The flow cytometry results showed that the first dose elicited SARS‐CoV‐2 specific cellular immunity, while the second dose strengthened SARS‐CoV‐2 specific IL‐2 + or TNF‐α + monofunctional, IFN‐γ + TNF‐α + bifunctional, and IFN‐γ − IL‐2 + TNF‐α + multifunctional CD4 + T cell responses ( p < 0.05). Moreover, SARS‐CoV‐2 specific memory T cells were generated after the first vaccination, including the central memory T cells and effector memory T cells. The present findings provide scientific evidence for the vaccination strategy of the inactive vaccines among children against COVID‐19 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19ChildHumansEast Asian PeopleInterleukin-2PandemicsProspective StudiesTumor Necrosis Factor-alphaSARS-CoV-2VaccinationImmunity, CellularAntibodies, NeutralizingImmunoglobulin GAntibodies, ViralImmunity, Humoral

Stichwörter der Autor:innen

T cell responseschildreninactivated COVID-19 vaccineneutralizing antibody

Substanzen

COVID-19 VaccinesInterleukin-2Tumor Necrosis Factor-alphaAntibodies, NeutralizingImmunoglobulin GAntibodies, Viral

Autor:innen und Institutionen

  • Department of Occupational and Environmental Health and Department of Epidemiology and Biostatistics, Ministry of Education and State Key Laboratory of Environmental Health, Huazhong University of Science and Technology…
  • Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Qichun Center for Disease Control and Prevention, Huanggang, China.

ORCID-Profile: Mengze Gan

Zitieren

APA

Wang, H., Gan, M., Wu, B., Zeng, R., Wang, Z., Xu, J., Li, J., Zhang, Y., Cao, J., Chen, L., Di, D., Peng, S., Lei, J., Zhao, Y., Song, X., Yuan, T., Zhou, T., Liu, Q., Yi, J., …, & Liu, L. (2023). Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study. Journal of Medical Virology. https://doi.org/10.1002/jmv.28380

Vancouver

Wang H, Gan M, Wu B, Zeng R, Wang Z, Xu J, et al. Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study. Journal of Medical Virology. 2023. doi:10.1002/jmv.28380

BibTeX
@article{Wang2023,
  author = {Wang, Hao and Gan, Mengze and Wu, Bihao and Zeng, Rui and Wang, Zhen and Xu, Jun and Li, Jia and Zhang, Yandi and Cao, Jinge and Chen, Li and Di, Dongsheng and Peng, Siyuan and Lei, Jinfeng and Zhao, Yingying and Song, Xuemei and Yuan, Tingting and Zhou, Tingting and Liu, Qian and Yi, Jing and Wang, Xi and Cai, Hao and Lei, Yanshou and Wen, Yuying and Li, Wenhui and Chen, Qinlin and Wang, Yufei and Long, Pinpin and Yuan, Yu and Wang, Chaolong and Pan, An and Wang, Qi and Gong, Rui and Fan, Xionglin and Wu, Tangchun and Liu, Li},
  title = {Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28380}
}
Kostenlos starten →